Adjuvant Nivolumab + Ipilimumab Lacks Efficacy for Localized RCC
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy r…
Learn MoreCausal Effect ID’d for IBD With Psoriasis, Psoriatic Arthritis
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — There seems to be a causal effect between inflammatory bowel disease and psoriasis and psoriatic arthritis, according to a study published online Sept. 14 in JAMA Dermatology.Dennis Freuer, Ph.D., from the…
Learn MoreMulticancer Early Detection Feasible for Outpatients
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at the …
Learn MoreGestational Weight Gain in the U.S. Higher During the Pandemic
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — The COVID-19 pandemic was associated with higher gestational weight gain (GWG) and a higher risk for excessive GWG among U.S. individuals with singleton pregnancies in 2020, according to a research letter …
Learn MoreCOVID-19 Hospitalization Rates Higher in Unvaccinated During Omicron
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — During the omicron variant COVID-19 spike, unvaccinated adults were more likely to be hospitalized than vaccinated adults, and hospitalization rates were lowest among those vaccinated and boosted, accordin…
Learn MoreTumefactive Demyelinating Lesions, Sentinel Lesions of PCNSL Compared
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Patients with typical tumefactive demyelinating lesions (TDLs) have younger age of onset than those with sentinel lesions of primary central nervous system lymphoma (PCNSL), and hypodense lesions are seen …
Learn MoreModel Shows Behavior Changes Could Cut CV Risk in Stage 1 HTN
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Substantial health and economic benefits could result from widespread adoption of nonpharmacologic interventions in lower-risk U.S. adults with stage 1 hypertension, according to a study presented at the A…
Learn MoreSome Ultraprocessed Foods May Lead to Broader Consumption for Teens
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Certain ultraprocessed food (UPF) products may act as gateway foods and increase subsequent consumption of other UPFs, according to a study presented at the American Heart Association Hypertension 2022 Sci…
Learn MoreMedical Cannabis Tied to Higher Risk for New Heart Rhythm Disorders
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — People with chronic pain who use medical cannabis have a higher risk for heart rhythm disorders versus nonusers, according to a study presented at the European Society of Cardiology Congress 2022, held fro…
Learn MoreVitamin D, Fish Oil Won’t Help Elderly Stay Strong, Study Finds
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — If only you could pop vitamin D and fish oil supplements to fight the frailty that often comes with aging, but new research delivers a disappointing message: Don’t count on it.In reaching that conclusion, …
Learn More